Jane Street’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-163,124
| Closed | -$1.54M | – | 12239 |
|
|
2026
Q1 | $1.54M | Sell |
163,124
-37,055
| -19% | -$407K | ﹤0.01% | 5588 |
|
|
2025
Q4 | $2.49M | Buy |
200,179
+180,581
| +921% | +$2.4M | ﹤0.01% | 4408 |
|
|
2025
Q3 | $281K | Sell |
19,598
-298,275
| -94% | -$4.09M | ﹤0.01% | 9037 |
|
|
2025
Q2 | $3.9M | Buy |
317,873
+263,059
| +480% | +$3.82M | ﹤0.01% | 3354 |
|
|
2025
Q1 | $1.21M | Sell |
54,814
-170,082
| -76% | -$4M | ﹤0.01% | 5221 |
|
|
2024
Q4 | $5.1M | Buy |
224,896
+164,083
| +270% | +$3.58M | ﹤0.01% | 2628 |
|
|
2024
Q3 | $1.1M | Sell |
60,813
-327,044
| -84% | -$7.58M | ﹤0.01% | 5675 |
|
|
2024
Q2 | $11.3M | Buy |
387,857
+262,970
| +211% | +$7.8M | ﹤0.01% | 1900 |
|
|
2024
Q1 | $4.43M | Buy |
124,887
+80,463
| +181% | +$3.22M | ﹤0.01% | 2803 |
|
|
2023
Q4 | $1.93M | Sell |
44,424
-4,574
| -9% | -$180K | ﹤0.01% | 4382 |
|
|
2023
Q3 | $1.87M | Sell |
48,998
-1,111
| -2% | -$46.7K | ﹤0.01% | 4164 |
|
|
2023
Q2 | $2.06M | Buy |
50,109
+9,255
| +23% | +$445K | ﹤0.01% | 4126 |
|
|
2023
Q1 | $2.35M | Buy |
40,854
+7,067
| +21% | +$398K | ﹤0.01% | 3548 |
|
|
2022
Q4 | $1.89M | Buy |
33,787
+6,722
| +25% | +$342K | ﹤0.01% | 3950 |
|
|
2022
Q3 | $1.15M | Sell |
27,065
-21,399
| -44% | -$1.1M | ﹤0.01% | 5167 |
|
|
2022
Q2 | $2.62M | Buy |
48,464
+16,578
| +52% | +$996K | ﹤0.01% | 3677 |
|
|
2022
Q1 | $2.05M | Sell |
31,886
-2,025
| -6% | -$133K | ﹤0.01% | 4708 |
|
|
2021
Q4 | $2.27M | Buy |
33,911
+22,509
| +197% | +$1.52M | ﹤0.01% | 4225 |
|
|
2021
Q3 | $781K | Buy |
+11,402
| New | +$806K | ﹤0.01% | 6415 |
|
|
2021
Q2 | – | Sell |
-15,210
| Closed | -$1.05M | – | 10046 |
|
|
2021
Q1 | $1.05M | Sell |
15,210
-34,632
| -69% | -$2.35M | ﹤0.01% | 5355 |
|
|
2020
Q4 | $3.23M | Buy |
+49,842
| New | +$2.68M | ﹤0.01% | 2727 |
|
|
2020
Q3 | – | Sell |
-22,379
| Closed | -$1.06M | – | 7475 |
|
|
2020
Q2 | $1.05M | Buy |
+22,379
| New | +$1.1M | ﹤0.01% | 3983 |
|
|
2019
Q3 | – | Sell |
-13,534
| Closed | -$756K | – | 5374 |
|
|
2019
Q2 | $756K | Buy |
+13,534
| New | +$697K | ﹤0.01% | 3053 |
|
|
2018
Q3 | – | Sell |
-68,353
| Closed | -$4.4M | – | 5367 |
|
|
2018
Q2 | $4.4M | Buy |
68,353
+61,079
| +840% | +$3.78M | 0.01% | 1155 |
|
|
2018
Q1 | $403K | Buy |
+7,274
| New | +$381K | ﹤0.01% | 3710 |
|
|
2017
Q3 | – | Sell |
-3,681
| Closed | -$201K | – | 4717 |
|
|
2017
Q2 | $201K | Buy |
+3,681
| New | +$176K | ﹤0.01% | 4030 |
|
|
2016
Q4 | – | Sell |
-27,608
| Closed | -$1.14M | – | 4270 |
|
|
2016
Q3 | $1.14M | Buy |
+27,608
| New | +$1.16M | 0.01% | 1803 |
|
|
2014
Q3 | – | Sell |
-10,446
| Closed | -$201K | – | 2768 |
|
|
2014
Q2 | $201K | Buy |
+10,446
| New | +$195K | ﹤0.01% | 2204 |
|
Other funds holding IART
RCMNY
PCMI
Jane Street's IART Position: Q2 2026 in Review
Jane Street sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 163,124 shares — an estimated $1.54M sold.
Jane Street first reported a position in IART in Q2 2014 and held it in 28 quarters. The position peaked at $11.3M in Q2 2024. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- Jane Street reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
- Jane Street sold 163,124 Integra LifeSciences shares in Q2 2026, an estimated $1.54M.
- Jane Street first reported a position in Integra LifeSciences in Q2 2014 and held it in 28 quarters.
- Jane Street's Integra LifeSciences position peaked at $11.3M in Q2 2024.
- 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.